Table 2.
Logistic analysis of the relationship between clinicopathologic features of HCC and the expression of TMEM147.
| Characteristics | Total (N) | Odds ratio (OR) | P value |
|---|---|---|---|
| T stage (T2 & T3 & T4 vs. T1) | 371 | 2.076 (1.375–3.149) | <0.001 |
| N stage (N1 vs. N0) | 258 | 72589629.123 (0.000–NA) | 0.994 |
| M stage (M1 vs. M0) | 272 | 2.743 (0.346–55.834) | 0.385 |
| Pathologic stage (Stage III & Stage IV vs. Stage I & Stage II) | 350 | 1.862 (1.147–3.056) | 0.013 |
| Histologic grade (G3 & G4 vs. G1 & G2) | 369 | 2.616 (1.695–4.075) | <0.001 |
| Tumor status (with tumor vs. tumor free) | 355 | 1.381 (0.907–2.108) | 0.133 |
| Fibrosis Ishak score (3/4 & 5/6 vs. 0 & 1/2) | 215 | 1.390 (0.810–2.395) | 0.233 |
| Residual tumor (R1 & R2 vs. R0) | 345 | 1.640 (0.630–4.555) | 0.318 |